DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 88 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q2 2019. The put-call ratio across all filers is 7.52 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $19 | -100.0% | 1,500 | -96.9% | 0.00% | -100.0% |
| Q2 2022 | $628,000 | -20.5% | 47,800 | -44.0% | 0.00% | 0.0% |
| Q1 2022 | $790,000 | -5.2% | 85,300 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $833,000 | +322.8% | 85,300 | +1370.7% | 0.00% | +200.0% |
| Q3 2021 | $197,000 | +6466.7% | 5,800 | +5700.0% | 0.00% | – |
| Q2 2021 | $3,000 | -25.0% | 100 | 0.0% | 0.00% | – |
| Q1 2021 | $4,000 | -20.0% | 100 | 0.0% | 0.00% | – |
| Q4 2020 | $5,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q3 2020 | $5,000 | -99.1% | 100 | -99.0% | 0.00% | -100.0% |
| Q2 2020 | $579,000 | +10.1% | 9,700 | -24.2% | 0.00% | 0.0% |
| Q1 2020 | $526,000 | -33.9% | 12,800 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $796,000 | -39.2% | 12,800 | -66.8% | 0.00% | 0.0% |
| Q3 2019 | $1,310,000 | +448.1% | 38,600 | +264.2% | 0.00% | +200.0% |
| Q2 2019 | $239,000 | -43.4% | 10,600 | -41.8% | 0.00% | -50.0% |
| Q1 2019 | $422,000 | +10.5% | 18,200 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $382,000 | -45.7% | 18,200 | 0.0% | 0.00% | -33.3% |
| Q3 2018 | $704,000 | +648.9% | 18,200 | +658.3% | 0.00% | – |
| Q2 2018 | $94,000 | +95.8% | 2,400 | 0.0% | 0.00% | – |
| Q1 2018 | $48,000 | -11.1% | 2,400 | 0.0% | 0.00% | – |
| Q4 2017 | $54,000 | – | 2,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 4,104,140 | $93,041,000 | 43.52% |
| SV Health Investors, LLC | 1,716,303 | $38,909,000 | 20.55% |
| PURA VIDA INVESTMENTS, LLC | 68,154 | $1,545,000 | 0.65% |
| Redmile Group, LLC | 683,880 | $14,658,000 | 0.64% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 77,000 | $1,746,000 | 0.62% |
| SPHERA FUNDS MANAGEMENT LTD. | 224,154 | $5,008,000 | 0.59% |
| EMERALD ADVISERS, LLC | 482,626 | $10,941,000 | 0.42% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 416,342 | $9,438,000 | 0.38% |
| Orbimed Advisors | 1,176,070 | $26,662,000 | 0.34% |
| VIKING GLOBAL INVESTORS LP | 2,394,625 | $54,286,000 | 0.33% |